ipilimumab,nivolumab,dostarlimab
bms,gsk
['biomarker', 'ipi/', 'nivo', 'rectal']
 my take. i d recommend it (had been doing it). it s makes scientific sense highly selected subset (&lt;1% of rectal) biomarker driven (dmmr/msi ) reliable marker e.g. pd-l1 chemo doesn t work do we need as well. enroll in ipi/nivo trial. agnostic 
Oncologist | Researcher | ColorectalCancer #CRCSM???????@MayoClinic @PittTweet Alum; ??#ctDNA #LiquidBiopsies??#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO22